The synthesis and spectroscopic analysis of the neurotoxic prion peptide 106-126: Comparative use of manual Boc and Fmoc chemistry

被引:0
|
作者
Michael F. Jobling
Colin J. Barrow
Anthony R. White
Colin L. Masters
Steven J. Collins
Roberto Cappai
机构
[1] The University of Melbourne,Department of Pathology
[2] The University of Melbourne,School of Chemistry
[3] The Mental Health Research Institute,Department of Pathology
[4] The University of Melbourne,undefined
来源
关键词
amyloid; circular dichroism; 'difficult sequence'; in situ neutralisation; N-(2-hydroxy-4-methoxybenzyl); tetramethylfluoroformamidinium hexafluorophosphate;
D O I
暂无
中图分类号
学科分类号
摘要
A peptide corresponding to residues 106-126 of the human prion protein (PrP) possesses the neurotoxic and amyloidogenic properties of the infectious form of the parental protein. This peptide is now identified as a 'difficult sequence' and synthesis using conventional manual Fmoc chemistry was unsuccessful with acylation terminating at a central core of hydrophobic amino acids. The use of tetramethylfluoroformamidinium hexafluorophosphate and 1-methyl-2- pyrrolidone as anti-aggregatory agents in the coupling steps improved the synthesis but still resulted in an incomplete peptide. The incorporation of N-(2-hydroxy-4-methoxybenzyl) protection at glycine residues 119 and 124 enabled synthesis of the full length peptide in low yield. Synthesis using Boc chemistry with in situ neutralisation gave the full length peptide in high yield.
引用
收藏
页码:129 / 134
页数:5
相关论文
共 8 条
  • [1] The synthesis and spectroscopic analysis of the neurotoxic prion peptide 106-126: Comparative use of manual Boc and Fmoc chemistry
    Jobling, MF
    Barrow, CJ
    White, AR
    Masters, CL
    Collins, SJ
    Cappai, R
    LETTERS IN PEPTIDE SCIENCE, 1999, 6 (2-3): : 129 - 134
  • [2] The synthesis and spectroscopic analysis of the neurotoxic prion peptide 106–126: Comparative use of manual Boc and Fmoc chemistry
    Michael F. Jobling
    Colin J. Barrow
    Anthony R. White
    Colin L. Masters
    Steven J. Collins
    Roberto Cappai
    Letters in Peptide Science, 1999, 6 : 129 - 134
  • [3] Critical evaluation of the use of DMB-dipeptides in the synthesis of neurotoxic prion peptide 106-126
    White, P. D.
    Beythien, J.
    Schneeberger, P.
    Keyte, J.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 134 - 134
  • [4] Prion peptide 106-126 modulates the aggregation of cellular prion protein and induces the synthesis of potentially neurotoxic transmembrane PrP
    Gu, YP
    Fujioka, H
    Mishra, RS
    Li, RL
    Singh, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) : 2275 - 2286
  • [5] The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126
    Jobling, MF
    Stewart, LR
    White, AR
    McLean, C
    Friedhuber, A
    Maher, F
    Beyreuther, K
    Masters, CL
    Barrow, CJ
    Collins, SJ
    Cappai, R
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 (04) : 1557 - 1565
  • [6] Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic
    Florio, T
    Paludi, D
    Villa, V
    Principe, DR
    Corsaro, A
    Millo, E
    Damonte, G
    D'Arrigo, C
    Russo, C
    Schettini, G
    Aceto, A
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 (01) : 62 - 72
  • [7] Study on the neurotoxic mechanism of prion using the protease-resistant protein and the synthetic peptide 106-126
    ELMoualij, B.
    Dupiereux, I.
    Zorzi, W.
    Zorzi, D.
    Pierard, O.
    Heinen, E.
    FEBS JOURNAL, 2006, 273 : 241 - 241
  • [8] Conformational properties of peptide fragments homologous to the 106-114 and 106-126 residues of the human prion protein: a CD and NMR spectroscopic study
    Di Natale, G
    Impellizzeri, G
    Pappalardo, G
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2005, 3 (03) : 490 - 497